Myrthe R Naber

5PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 21, 2026
Clinical and endoscopic features of checkpoint inhibitor-induced colitis and their association with selective immunosuppressive therapy use.

|Apr 04, 2026
Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Loriane M M Verleye, Marieke J Pierik, Annemarie C de Vries

|Dec 05, 2025
Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry.

M R Naber, A E van der Meulen, P W Voorneveld

|Jan 21, 2022
Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?

Myrthe R Naber, Saya Ahmad, Annemarie A Verrijn Stuart

Pageof 1

Frequent Collaborators

2 joint publications

Philip W Voorneveld

2 joint publications

Zlatan Mujagić

2 joint publications

Loriane M M Verleye

2 joint publications

Marjolijn Duijvestein